Edwards Lifesciences Corporation Common Stock vs State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF trades at $30.76 (market cap $3.06B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 16.2× State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF's market cap, and State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF is more actively traded (465,116 versus 3,508,027). Which is the better fit depends on your goals.
| EW | FLRN | |
|---|---|---|
Market Cap | $49.44B | $3.06B |
Volume | 3,508,027 | 465,116 |
Sector | Health | Fixed Income |
52-Week High | $95.18 | $30.86 |
52-Week Low | $72.65 | $30.65 |
Enterprise Value | $45.90B | — |
Typical Hold Time | — | 15 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FLRN (SPDR Bloomberg Investment Grade Floating Rate ETF) trades at $30.75 with minimal daily movement (+0.03%). Technical indicators show a bearish trend with strong selling pressure in moving averages, while oscillators remain neutral. The ETF maintains consistent $0.11 quarterly dividend payments through 2026, providing income stability amid current market volatility.
FLRN offers protection against rising interest rates with near-zero duration exposure, though significant financial sector concentration presents risk. Current market sentiment reflects cautious optimism as institutional investors add positions while technical indicators suggest near-term pressure. The floating rate structure positions FLRN favorably in inflationary environments.
Trailing returns across standard periods
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →FLRN invests in U.S. dollar-denominated investment-grade floating rate notes with maturities under five years. It provides exposure to corporate and supranational debt whose interest payments adjust with market rates, helping to mitigate interest rate risk.
Read more on FLRN →